2.395
Schlusskurs vom Vortag:
$2.42
Offen:
$2.39
24-Stunden-Volumen:
73,084
Relative Volume:
0.74
Marktkapitalisierung:
$99.92M
Einnahmen:
$6.21M
Nettoeinkommen (Verlust:
$-19.92M
KGV:
-2.281
EPS:
-1.05
Netto-Cashflow:
$-16.76M
1W Leistung:
-1.03%
1M Leistung:
+0.63%
6M Leistung:
-7.88%
1J Leistung:
-9.62%
InspireMD Inc. Stock (NSPR) Company Profile
Firmenname
InspireMD Inc.
Sektor
Branche
Telefon
972 3 6917691
Adresse
4 Menorat Hamaor Street, Tel Aviv
Vergleichen Sie NSPR mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
NSPR
InspireMD Inc.
|
2.395 | 100.96M | 6.21M | -19.92M | -16.76M | -1.05 |
![]()
ABT
Abbott Laboratories
|
133.26 | 228.66B | 43.11B | 13.94B | 6.78B | 7.9963 |
![]()
BSX
Boston Scientific Corp
|
96.24 | 140.69B | 18.49B | 2.50B | 3.49B | 1.6801 |
![]()
SYK
Stryker Corp
|
369.88 | 139.51B | 23.82B | 2.92B | 4.02B | 7.5574 |
![]()
MDT
Medtronic Plc
|
96.53 | 122.60B | 34.20B | 4.69B | 5.30B | 3.6218 |
![]()
EW
Edwards Lifesciences Corp
|
73.35 | 42.83B | 5.69B | 1.41B | 577.90M | 6.9828 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2016-01-07 | Eingeleitet | Rodman & Renshaw | Buy |
2015-03-13 | Herabstufung | Oppenheimer | Outperform → Perform |
2013-11-26 | Eingeleitet | Oppenheimer | Outperform |
InspireMD Inc. Aktie (NSPR) Neueste Nachrichten
Can InspireMD Inc. stock weather global recessionJuly 2025 Price Swings & Accurate Trade Setup Notifications - newser.com
Real time breakdown of InspireMD Inc. stock performanceRecession Risk & Weekly Chart Analysis and Guides - newser.com
Market reaction to InspireMD Inc.’s recent newsFed Meeting & Fast Gain Stock Tips - newser.com
Can swing trading help recover from InspireMD Inc. lossesCEO Change & Fast Momentum Entry Tips - newser.com
Short interest data insights for InspireMD Inc.Exit Point & Safe Entry Trade Signal Reports - newser.com
What margin trends mean for InspireMD Inc. stock2025 Stock Rankings & Technical Pattern Based Signals - newser.com
Detecting price anomalies in InspireMD Inc. with AIJuly 2025 Technicals & Real-Time Volume Triggers - newser.com
Risk adjusted return profile for InspireMD Inc. analyzedTrade Entry Summary & Long-Term Safe Return Strategies - newser.com
Can InspireMD Inc. (II2) stock expand revenue streamsEarnings Recap Report & Fast Moving Stock Watchlists - newser.com
Technical analysis overview for InspireMD Inc. stockAnalyst Upgrade & Free Expert Verified Stock Movement Alerts - newser.com
Is InspireMD Inc. (II2) stock among top earnings playsWeekly Trading Summary & Long-Term Investment Growth Plans - newser.com
How risky is InspireMD Inc. (II2) stock compared to peersStock Surge & AI Driven Price Predictions - newser.com
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
InspireMD announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
40,513 Restricted Shares: InspireMD Grants Inducements to 3 New Employees with 3-Year Vesting - Stock Titan
Sector ETF performance correlation with InspireMD Inc.July 2025 Retail & Advanced Technical Signal Analysis - newser.com
Predicting InspireMD Inc. trend using moving averagesTrade Analysis Summary & Daily Profit Maximizing Tips - newser.com
Combining machine learning predictions for InspireMD Inc.July 2025 Price Swings & High Return Trade Guides - newser.com
Can InspireMD Inc. (II2) stock attract ESG investmentsSell Signal & Fast Exit and Entry Strategy Plans - newser.com
How to recover losses in InspireMD Inc. stockBuy Signal & Weekly Breakout Opportunity Watchlist - newser.com
How InspireMD Inc. (II2) stock reacts to stronger dollarRisk Management & Daily Risk Controlled Trade Plans - newser.com
Will InspireMD Inc. (II2) stock outperform foreign stocksBull Run & Low Drawdown Investment Ideas - newser.com
InspireMD Inc II2 Stock Analysis and ForecastGrowth Stock Opportunities & Buy Sell Signal Notifications - earlytimes.in
Finanzdaten der InspireMD Inc.-Aktie (NSPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):